Literature DB >> 23687610

A case of mesenteric ischemia secondary to Fibromuscular Dysplasia (FMD) with a positive outcome after intervention.

Neal C Patel1, William C Palmer, Kanwar R S Gill, Michael B Wallace.   

Abstract

Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic angiopathy, which commonly affects the renal and internal carotid arteries. Although rare, FMD has the potential of involving the mesenteric vasculature. Due its low incidence and relatively little knowledge concerning its risk factors and etiology, actual diagnosis of FMD involving the mesenteric vessels requires a very high degree of suspicion. Upon review of the few reported cases of FMD causing mesenteric ischemia, it is clear that therapeutic interventions are rarely discussed and that positive outcomes are even more uncommon. Herein, we present the case of a 47 year-old female with mesenteric ischemia secondary to FMD, which was diagnosed and treated originally with angioplasty, then repeat angioplasty with stent placement, and finally with a bypass graft. Ultimately, the patient had a positive outcome, including eight month follow-up.

Entities:  

Keywords:  abdominal pain; fibromuscular displasia; mesenteric ischemia

Year:  2012        PMID: 23687610      PMCID: PMC3655395          DOI: 10.4161/jig.23747

Source DB:  PubMed          Journal:  J Interv Gastroenterol        ISSN: 2154-1280


  9 in total

Review 1.  Fibromuscular dysplasia.

Authors:  S M Begelman; J W Olin
Journal:  Curr Opin Rheumatol       Date:  2000-01       Impact factor: 5.006

Review 2.  Fibromuscular dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

3.  Pathologic classification of renal arterial disease in renovascular hypertension.

Authors:  E G Harrison; L J McCormack
Journal:  Mayo Clin Proc       Date:  1971-03       Impact factor: 7.616

4.  Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics.

Authors:  K L Mettinger; K Ericson
Journal:  Stroke       Date:  1982 Jan-Feb       Impact factor: 7.914

Review 5.  Arterial fibromuscular dysplasia.

Authors:  T F Lüscher; J T Lie; A W Stanson; O W Houser; L H Hollier; S G Sheps
Journal:  Mayo Clin Proc       Date:  1987-10       Impact factor: 7.616

6.  Rupture of a hepatic artery aneurysm and renal infarction: 2 complications of fibromuscular dysplasia that mimic vasculitis.

Authors:  H J Jones; R Staud; R C Williams
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

7.  The genetics of fibromuscular dysplasia.

Authors:  A R Rushton
Journal:  Arch Intern Med       Date:  1980-02

Review 8.  Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature.

Authors:  Carrie K Guill; Diana C Benavides; Chet Rees; Andrew Z Fenves; Elizabeth C Burton
Journal:  Arch Intern Med       Date:  2004-05-24

9.  Etiologic factors in renovascular fibromuscular dysplasia. A case-control study.

Authors:  C N Sang; P K Whelton; U M Hamper; M Connolly; S Kadir; R I White; R Sanders; K Y Liang; W Bias
Journal:  Hypertension       Date:  1989-11       Impact factor: 10.190

  9 in total
  3 in total

1.  Massive mesenteric panniculitis due to fibromuscular dysplasia of the inferior mesenteric artery: a case report.

Authors:  Andrew Mitchell; Véronique Caty; Yves Bendavid
Journal:  BMC Gastroenterol       Date:  2015-06-23       Impact factor: 3.067

Review 2.  Rare Mesenteric Arterial Diseases: Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review.

Authors:  Masayoshi Ko; Kenya Kamimura; Akira Sakamaki; Yusuke Niwa; Kentaro Tominaga; Kenichi Mizuno; Shuji Terai
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

Review 3.  Diagnosis and management of fibromuscular dysplasia and segmental arterial mediolysis in gastroenterology field: A mini-review.

Authors:  Masayoshi Ko; Kenya Kamimura; Kohei Ogawa; Kentaro Tominaga; Akira Sakamaki; Hiroteru Kamimura; Satoshi Abe; Kenichi Mizuno; Shuji Terai
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.